Biologic Therapies for Wound Care: Technologies and Global Markets

Description

List of Tables

The global market for wound care biologics is expected to grow from $7 billion in 2025 and is projected to reach $10.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2025 to 2030.

The North American market for wound care biologics is expected to grow from $3.1 billion in 2025 and is projected to reach $4.7 billion by the end of 2030, at a CAGR of 9% during the forecast period of 2025 to 2030.

The European market for wound care biologics is expected to grow from $2.2 billion in 2025 and is projected to reach $3.4 billion by the end of 2030, at a CAGR of 8.7% during the forecast period of 2025 to 2030.

Report Scope

The global wound care biologics report provides an overview and analyzes market trends. The report includes global revenue ($ million) for the base year data (2024) and estimated data for the forecast period (2025 through 2030). The market is segmented by product type, application, end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, and the rest of the World (RoW), with a focus on major countries in each region.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also discusses emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, including rankings of key companies in the global wound care biologics market. It also features a dedicated section of company profiles that covers details such as overview, key financials, product portfolio, and recent developments of key companies.

Report Includes

78 data tables and 61 additional tables
Overview and an analysis of the global market for wound care biologics and related technologies
Analyses of the global market trends, with historic data from 2022 to 2025, and projections of CAGRs through 2030
Estimates of the market size and revenue prospects for the global market, accompanied by a market share analysis by product type, application, end user, and region
Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impact of macroeconomic variables
Insights derived from Porter's Five Forces model, as well as global supply chain analyses
Patent review, featuring key granted and published patents
Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
Profiles of the leading global companies, including Convatec Group PLC., Integra LifeSciences Corp., MIMEDX Group Inc., and Organogenesis Inc.

Product Code: BIO228B

Chapter 1 Executive Summary

Market Outlook
Scope of the Report
Market Summary
Market Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

History of Wound Care
Technology Background
Types of Wounds
Wound Healing Process
Hemostasis
Inflammation
Proliferation
Maturation or Remodeling
ECM Composition and Its Importance in Skin Wound Healing
Biologic Therapies for Wound Care
Autologous
Allogeneic
Heterologous/Xenogenic
Macroeconomic Factors Analysis
PESTEL Analysis
Impact of U.S. Tariff Laws on the Wound Care Biologics Market
Porter's Five Forces Analysis
Potential for New Entrants (Moderate to High)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (High)
Threat of Substitutes (High)
Competition in the Industry (High)

Chapter 3 Market Dynamics

Market Drivers
Growing Geriatric Population
Increasing Prevalence of Diabetes and Target Conditions
Increasing Incidence of Burn Injuries
Innovations in Wound Care Biologics
Market Restraints
High Cost and Lack of Skilled Workforce
Unfavorable Reimbursement Scenario
Complex Regulatory Framework
Market Opportunities
Growing Industry Collaborations in Wound Care Biologics Market
Growth Opportunities in Emerging Markets

Chapter 4 Regulatory Landscape

FDA Regulatory Review and Approval Process
Premarket Approval (PMA)
510(k) Clearance
Biologics License Application
Human Cells, Tissues, and Cellular and Tissue-based Products (HCT/Ps)
Coverage and Reimbursement
Medicare Coverage
Medicaid
Private Payers

Chapter 5 Emerging Technologies and New Developments

Overview
Smart Dressings and Bioactive Nanomaterials
3D Bioprinting
Artificial Intelligence (AI) in Wound Care Biologics

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Market Breakdown by Product Type
Key Takeaways
Cellular and Tissue-Based Products (CTPs)/Skin Substitutes
Acellular CTPs
Cellular CTPs
Biologic Skin Substitute
Bioengineered Skin Substitutes
Topical Agents
Keratin Proteins
Enzymatic Debridement Agents
Market Breakdown by Application
Key Takeaways
Chronic Wounds
Acute Wounds
Market Breakdown by End User
Key Takeaways
Ambulatory Surgery Centers (ASCs)
Hospitals
Burn Care Centers and Wound Clinics
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Chapter 7 Competitive Intelligence

Key Takeaways
Top Companies Ranking in Wound Care Biologics Market, 2024
Key Companies by Product Type
Allografts
Acellular Animal-Derived Tissue-Based Products/Xenografts
Strategic Analysis

Chapter 8 Appendix

Methodology
Abbreviations
References
Company Profiles
ABBVIE INC.
AROA BIOSURGERY LTD.
BIOTISSUE
BIOVENTUS
CELLUTION BIOLOGICS INC.
CONVATEC GROUP PLC
ELUTIA
FIBROHEAL
INTEGRA LIFESCIENCES CORP.
JOHNSON & JOHNSON
MIMEDX GROUP INC.
ORGANOGENESIS INC.
SKYE BIOLOGICS HOLDINGS LLC.
SMITH + NEPHEW
STRYKER
ZIMMER BIOMET

Product Code: BIO228B

List of Tables

Summary Table : Global Market for Wound Care Biologics, by Region, Through 2030
Table 1 : ECM Components and Their Role in Wound Healing
Table 2 : Number and Distribution of Persons Age 60+, by Region, 2019 and 2050
Table 3 : Global Prevalence of Diabetes, by Population Segment, Through 2045
Table 4 : Recent Industry Collaborations in Wound Care Biologics Market, 2024-2025
Table 5 : Emerging Nanotherapeutic Approaches for Wound Healing Applications
Table 6 : Emerging Bioprinting Methods for Wound Healing Applications
Table 7 : Global Market for Wound Care Biologics, by Product Type, Through 2030
Table 8 : Global Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 9 : Global Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 10 : Global Market for Wound Care Biologics for Acellular CTPs, by Region, Through 2030
Table 11 : Global Market for Wound Care Biologics for Cellular CTPs, by Region, Through 2030
Table 12 : Global Market for Wound Care Biologics for Biologic Skin Substitutes, by Region, Through 2030
Table 13 : Global Market for Wound Care Biologics for Biologic Skin Substitute, by Tissue Source, Through 2030
Table 14 : Placental Allograft Products
Table 15 : Global Market for Wound Care Biologics for Allografts, by Region, Through 2030
Table 16 : Acellular Animal-Derived Tissue-Based Products/Xenografts
Table 17 : Global Market for Wound Care Biologics for Xenografts, by Region, Through 2030
Table 18 : Global Market for Wound Care Biologics for Bioengineered Skin Substitute, by Composition, Through 2030
Table 19 : Global Market for Wound Care Biologics for Bioengineered Skin Substitute, by Region, Through 2030
Table 20 : Human Cellular Bioengineered Skin Substitutes
Table 21 : Global Market for Wound Care Biologics for Cellular Bioengineered Skin Substitute, by Region, Through 2030
Table 22 : Biosynthetic Skin Substitutes
Table 23 : Global Market for Wound Care Biologics for Acellular Bioengineered Skin Substitute, by Region, Through 2030
Table 24 : Global Market for Wound Care Biologics for Topical Agents, by Region, Through 2030
Table 25 : Examples of Commercially Available Topical Agents
Table 26 : Global Market for Wound Care Biologics, by Application, Through 2030
Table 27 : Global Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 28 : Global Market for Wound Care Biologics for Chronic Wounds, by Region, Through 2030
Table 29 : Global Market for Wound Care Biologics for Venous Ulcers, by Region, Through 2030
Table 30 : Global Market for Wound Care Biologics for Diabetic Foot Ulcers, by Region, Through 2030
Table 31 : FDA-Approved Wound Care Biologics for DFU Treatment
Table 32 : Wound Care Biologics in Clinical Trials for DFU Treatment
Table 33 : Global Market for Wound Care Biologics for Pressure Ulcers, by Region, Through 2030
Table 34 : Global Market for Wound Care Biologics for Arterial and Other Ulcers, by Region, Through 2030
Table 35 : Global Market for Wound Care Biologics for Acute Wounds, by Type, Through 2030
Table 36 : Global Market for Wound Care Biologics for Acute Wounds, by Region, Through 2030
Table 37 : Global Market for Wound Care Biologics for Surgical and Traumatic Wounds, by Region, Through 2030
Table 38 : Burn Classifications
Table 39 : Global Market for Wound Care Biologics for Burns, by Region, Through 2030
Table 40 : Global Market for Wound Care Biologics, by End User, Through 2030
Table 41 : Global Market for Wound Care Biologics for Ambulatory Surgery Centers, by Region, Through 2030
Table 42 : Global Market for Wound Care Biologics for Hospitals, by Region, Through 2030
Table 43 : Global Market for Wound Care Biologics for Burn Care Centers and Wound Clinics, by Region, Through 2030
Table 44 : Global Market for Wound Care Biologics, by Region, Through 2030
Table 45 : North American Market for Wound Care Biologics, by Product Type, Through 2030
Table 46 : North American Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 47 : North American Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 48 : North American Market for Wound Care Biologics, by Application, Through 2030
Table 49 : North American Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 50 : North American Market for Wound Care Biologics for Acute Wounds, by Type Through 2030
Table 51 : North American Market for Wound Care Biologics, by End User, Through 2030
Table 52 : North American Market for Wound Care Biologics, by Country, Through 2030
Table 53 : European Market for Wound Care Biologics, by Product Type, Through 2030
Table 54 : European Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 55 : European Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 56 : European Market for Wound Care Biologics, by Application, Through 2030
Table 57 : European Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 58 : European Market for Wound Care Biologics for Acute Wounds, by Type, Through 2030
Table 59 : European Market for Wound Care Biologics, by End User, Through 2030
Table 60 : European Market for Wound Care Biologics, by Country, Through 2030
Table 61 : Asia-Pacific Market for Wound Care Biologics, by Product Type, Through 2030
Table 62 : Asia-Pacific Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 63 : Asia-Pacific Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 64 : Asia-Pacific Market for Wound Care Biologics, by Application, Through 2030
Table 65 : Asia-Pacific Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 66 : Asia-Pacific Market for Wound Care Biologics for Acute Wounds, by Type, Through 2030
Table 67 : Asia-Pacific Market for Wound Care Biologics, by End User, Through 2030
Table 68 : Asia-Pacific Market for Wound Care Biologics, by Country, Through 2030
Table 69 : Rest of the World Market for Wound Care Biologics, by Product Type, Through 2030
Table 70 : Rest of the World Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 71 : Rest of the World Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 72 : Rest of the World Market for Wound Care Biologics, by Application, Through 2030
Table 73 : Rest of the World Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 74 : Rest of the World Market for Wound Care Biologics for Acute Wounds, by TypeThrough 2030
Table 75 : Rest of the World Market for Wound Care Biologics, by End User, Through 2030
Table 76 : Rest of the World Market for Wound Care Biologics, by Sub-Region, Through 2030
Table 77 : Top Companies Ranking, 2024
Table 78 : Key Wound Care Biologics Manufacturers' Offerings
Table 79 : Leading Companies in Allografts
Table 80 : Key Companies' Allograft Offerings, by Product Type
Table 81 : Leading Acellular Animal-Derived Tissue-Based Products/Xenografts
Table 82 : Recent Developments in the Wound Care Biologics Market, 2023-2025
Table 83 : Abbreviations Used in This Report
Table 84 : AbbVie Inc.: Company Snapshot
Table 85 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 86 : AbbVie Inc.: Product Portfolio
Table 87 : AbbVie Inc.: News/Key Developments, 2023-2025
Table 88 : Aroa Biosurgery Ltd.: Company Snapshot
Table 89 : Aroa Biosurgery Ltd.: Financial Performance, FY 2023 and 2024
Table 90 : Aroa Biosurgery Ltd.: Product Portfolio
Table 91 : Aroa Biosurgery Ltd.: News/Key Developments, 2023-2024
Table 92 : BioTissue: Company Snapshot
Table 93 : BioTissue: Product Portfolio
Table 94 : BioTissue: News/Key Developments, 2023-2025
Table 95 : Bioventus: Company Snapshot
Table 96 : Bioventus: Financial Performance, FY 2023 and 2024
Table 97 : Bioventus: Product Portfolio
Table 98 : Cellution Biologics Inc.: Company Snapshot
Table 99 : Cellution Biologics Inc.: Product Portfolio
Table 100 : Cellution Biologics Inc.: News/Key Developments, 2024-2025
Table 101 : Convatec Group PLC: Company Snapshot
Table 102 : Convatec Group PLC: Financial Performance, FY 2023 and 2024
Table 103 : Convatec Group PLC: Product Portfolio
Table 104 : Convatec Group PLC: News/Key Developments, 2025
Table 105 : Elutia: Company Snapshot
Table 106 : Elutia: Financial Performance, FY 2023 and 2024
Table 107 : Elutia: Product Portfolio
Table 108 : Elutia: News/Key Developments, 2024-2025
Table 109 : Fibroheal: Company Snapshot
Table 110 : Fibroheal: Product Portfolio
Table 111 : Fibroheal: News/Key Developments, 2024
Table 112 : Integra LifeSciences Corp.: Company Snapshot
Table 113 : Integra LifeSciences Corp.: Financial Performance, FY 2023 and 2024
Table 114 : Integra LifeSciences Corp.: Product Portfolio
Table 115 : Integra LifeSciences Corp.: News/Key Developments, 2024
Table 116 : Johnson & Johnson: Company Snapshot
Table 117 : Johnson & Johnson: Financial Performance, FY 2023 and 2024
Table 118 : Johnson & Johnson: Product Portfolio
Table 119 : MIMEDX Group Inc.: Company Snapshot
Table 120 : MIMEDX Group Inc.: Financial Performance, FY 2023 and 2024
Table 121 : MIMEDX Group Inc.: Product Portfolio
Table 122 : MIMEDX Group Inc.: News/Key Developments, 2022-2024
Table 123 : Organogenesis Inc.: Company Snapshot
Table 124 : Organogenesis Inc.: Financial Performance, FY 2023 and 2024
Table 125 : Organogenesis Inc.: Product Portfolio
Table 126 : Skye Biologics Holdings LLC.: Company Snapshot
Table 127 : Skye Biologics Holdings LLC.: Product Portfolio
Table 128 : Smith+Nephew: Company Snapshot
Table 129 : Smith+Nephew: Financial Performance, FY 2023 and 2024
Table 130 : Smith+Nephew: Product Portfolio
Table 131 : Smith+Nephew: News/Key Developments, 2023-2024
Table 132 : Stryker: Company Snapshot
Table 133 : Stryker: Financial Performance, FY 2023 and 2024
Table 134 : Stryker: Product Portfolio
Table 135 : Stryker: News/Key Developments, 2025
Table 136 : Zimmer Biomet: Company Snapshot
Table 137 : Zimmer Biomet: Financial Performance, FY 2023 and 2024
Table 138 : Zimmer Biomet: Product Portfolio

List of Figures

Summary Figure : Summary Figure: Global Market Shares of Wound Care Biologics, by Region, 2024
Figure 1 : Stages of Wound Healing
Figure 2 : PESTEL Analysis: Wound Care Biologics Market
Figure 3 : Porter's Five Forces Analysis of the Wound Care Biologics Market
Figure 4 : Snapshot of the Market Dynamics for Wound Care Biologics
Figure 5 : Estimated Number of People Aged 20 to 79 with Diabetes, Globally, 2000-2024
Figure 6 : Emerging Technologies in Wound Care Biologics Market
Figure 7 : Global Market Shares of Wound Care Biologics, by Product Type, 2024
Figure 8 : Global Market Shares of Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, 2024
Figure 9 : Global Market Shares of Wound Care Biologics for Cellular and Tissue-Based Products, by Material, 2024
Figure 10 : Global Market Shares of Biologic Skin Substitute, by Tissue Source, 2024
Figure 11 : Global Market Shares of Wound Care Biologics for Bioengineered Skin Substitute, by Composition, 2024
Figure 12 : Global Market Shares of Wound Care Biologics, by Application, 2024
Figure 13 : Global Market Shares of Chronic Wounds, by Type, 2024
Figure 14 : Global Market Shares of Acute Wounds, by Type, 2024
Figure 15 : Global Market Shares of Wound Care Biologics, by End User, 2024
Figure 16 : Global Market Shares of Wound Care Biologics, by Region, 2024
Figure 17 : North American Market Shares of Wound Care Biologics, by Country, 2024
Figure 18 : U.S. Elderly Population (65 and Older), 2010-2050
Figure 19 : European Market Shares of Wound Care Biologics, by Country, 2024
Figure 20 : Asia-Pacific Market Shares of Wound Care Biologics, by Country, 2024
Figure 21 : Rest of the World Market Shares of Wound Care Biologics, by Sub-Region, 2024
Figure 22 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 23 : AbbVie Inc.: Revenue Shares, by Region/Country, FY 2024
Figure 24 : Aroa Biosurgery Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 25 : Aroa Biosurgery Ltd.: Revenue Shares, by Region/Country, FY 2024
Figure 26 : Bioventus: Revenue Shares, by Region, FY 2024
Figure 27 : Convatec Group PLC: Revenue Shares, by Business Unit, FY 2024
Figure 28 : Convatec Group PLC: Revenue Shares, by Region, FY 2024
Figure 29 : Elutia: Revenue Shares, by Business Unit, FY 2024
Figure 30 : Integra LifeSciences Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 31 : Integra LifeSciences Corp.: Revenue Shares, by Region, FY 2024
Figure 32 : Johnson & Johnson: Revenue Shares, by Business Segment, FY 2024
Figure 33 : Johnson & Johnson: Revenue Shares, by Country/Region, FY 2024
Figure 34 : MIMEDX Group Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 35 : Organogenesis Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 36 : Smith+Nephew: Revenue Shares, by Business Unit, FY 2024
Figure 37 : Smith+Nephew: Revenue Shares, by Country/Region, FY 2024
Figure 38 : Stryker: Revenue Shares, by Business Unit, FY 2024
Figure 39 : Stryker: Revenue Shares, by Country/Region, FY 2024
Figure 40 : Zimmer Biomet: Revenue Shares, by Business Unit, FY 2024
Figure 41 : Zimmer Biomet: Revenue Shares, by Country/Region, FY 2024

Biologic Therapies for Wound Care: Technologies and Global Markets

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Technologies and New Developments

Chapter 6 Market Segmentation Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Appendix

List of Tables

List of Figures